Learn
Research Article
Vorasidenib in IDH-mutant low grade gliomas (Research Article)
This is a research paper and summary about a study (INDIGO trial) using a medication called Vorasidenib in over 300 patients with grade 2 glioma who had an IDH mutation. The research showed the drug significantly slowed tumour growth in the patients taking Vorasidenib compared to patients taking a placebo, and suggests there may be a new treatment…
Read more